Drug Development Consulting BidCo ApS: Financial statements 2024
CVR: 42287067
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Drug Development Consulting BidCo ApS (CVR 42287067) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 3,438,000 and a net result of DKK -13,215,000 compared with DKK -9,381,000 the year before. That is an increase of 48.2% compared with the year before. Equity in the 2024 report amounted to DKK 78,983,000. The solvency ratio was 62.7%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 3,438,000
- Profit/Loss
- DKK -13,215,000
- Equity
- DKK 78,983,000
- Total Assets
- DKK 126,045,000
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 3.4M | -13.2M | 79M | 1 |
| 2023 | - | 2.3M | -9.4M | 70.2M | 1 |
| 2022 | - | 3.8M | -11.8M | 71.8M | 1 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Drug Development Consulting BidCo ApS has published its annual report for 2023. Gross profit came to DKK 2,320,000, and the net result was DKK -9,381,000.
As of April 25, 2024, Mette Kirstine Agger has left the board of directors of Drug Development Consulting BidCo ApS.
About Drug Development Consulting BidCo ApS
Drug Development Consulting BidCo ApS is a Danish company of the type Anpartsselskab based in Brøndby, founded in 2021. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The management consists of René Holmen Pedersen. The board consists of Niels Peder Nielsen (chair), Alejandra Maria Cristina Bonifacini Mørk, Rafael Natanek and Redmar Koene. The company is owned by Drug Development Consulting Holding ApS. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 5,875,000 and a net result of DKK -61,325,000 compared with DKK -13,215,000 the year before. Equity in the 2025 report amounted to DKK 32,493,000.
